Kisha Sivanathan, a PhD student leading a team of researchers at the University of Adelaide, Australia, identified a major breakthrough in the cultivation and application of mesenchymal stem cells [MSC]. The research group looked at the interaction between MSCs and IL-17, a naturally occurring protein that occurs in the body during immune responses. The cells treated with IL-17 not only showed faster growth rates, but prevented the risk of potential rejection of stem cell tissue transplants.
“We discovered that when cultured mesenchymal stem cells are treated with IL-17 they grow twice as fast as the untreated stem cells and are more efficient at regulating the body’s immune response,” said Ms. Sivanathan. This may have implications for chemotherapy, which often obliterates the full immune spectrum; IL-17-treated cells may confer extra immunoprotection to cancer patients.
This advance in stem cell physiological behavior will likely produce more effective therapies in the future; clinical trials are the next step in elucidating the process by which IL-17-exposed mesenchymal cells protect and promote cell health. To learn more about stem cells, and how families can bank their own valuable stem cells by recovering the very powerful dental pulp stem cells during routine dental procedures; such as wisdom teeth extractions or the during the loss of baby teeth, visit StemSave or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The Future of Regenerative Medicine is Now™.